Alamar Biosciences, Inc. (California) (ALMR)
34.36
+1.90
(+5.85%)
USD |
NASDAQ |
Oct 02, 16:00
34.62
+0.26
(+0.76%)
Pre-Market: 20:00
Alamar Biosciences Total Liabilities (Quarterly) : 78.12M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.12M |
| Date | Value |
|---|---|
| March 31, 2026 | 364.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| 10X Genomics, Inc. | 204.52M |
| Personalis, Inc. | 76.97M |
| Adaptive Biotechnologies Corp. | 490.02M |
| Champions Oncology, Inc. | 28.83M |
| Medpace Holdings, Inc. | 1.623B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 390.98M |
| Shareholders Equity (Quarterly) | 312.86M |
| Debt to Equity Ratio | 0.1643 |
| Current Ratio | 11.85 |
| Net Debt Paydown Yield | 0.83% |